There will be two RIGH companies: One parent company Bud Genius, Inc. listed on the OTC Pink, and one subsidiary (separately reporting) listed on the OTC:QB, Genius Biotech Corp.
"Are there plans to file an S-1 registration statement on OTC:QB? If so, will Bud Genius shareholders receive a dividend?
The company has announced its plans to launch a new subsidiary, Genius Biotech Corporation, to specialize in the healthcare aspects of medical marijuana. The company plans to file an S-1 registration statement, be fully audited, fully reporting, Sarbanes-Oxley compliant, and list on the OTC:QB. BG Medical Technologies will place its medical device, treatment solutions, and product manufacturing projects into Genius Biotech Corporation as a stand-alone corporation with its own growth potential.
Please stay tuned and watch for more information."
...
"Does the company have plans for a reverse split?
No. As long as the current management is in place, we will never do a reverse stock split. The only circumstance where that could possibly serve the interests of company and shareholders would be prior to an exchange uplisting. Since there are no current plans to place Bud Genius, Inc. on the OTC:QB exchange, this is not an option."
News 
Market Data 
Discover 
